Replies to post #3952 on Geron Corp (GERN)

[davidsson10]

"Geron expects the longer-term data from the trial, potential health authority feedback, and the totality of imetelstat program information, including an assessment of the evolving treatment landscape in MF and the potential application of imetelstat in multiple hematologic malignancies, including MDS, will inform Janssen's decision whether to continue development of imetelstat in relapsed or refractory MF."

[redskins020]

Seems to me J & J wouldn't want to overplay their hand too early, why start a bidding war from companies looking to take over Heron !

[subslover]

Geron settling class-action securities suit for $6.25M
Apr. 10, 2017 7:00 PM ET|About: Geron Corporation (GERN)|By: Jason Aycock, SA News Editor
Geron (GERN +19.5%) says in a filing that it's entered into a settlement resolving a consolidated class-action securities lawsuit.
In exchange for dismissal with prejudice of all claims against all defendants in the matter, Geron is settling for $6.25M in cash -- $6M of which will be paid by Geron's insurers, with the company ponying up $250K and admitting no wrongdoing.
The class consisted of buyers of the company's stock between Dec. 10, 2012 through and including March 11, 2014.
The settlement heads for a fairness hearing on July 21, 2017.